IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION
$2,604N01FY2021CANIH
University Of Tx Md Anderson Can Ctr, Houston TX
Investigators
Abstract
The overall objective of this task order shall be to perform a pilot clinical trial testing the effects of aspirin on biomarkers associated with risk of recurrence of BE and/or esophageal adenocarcinoma in post-ablation esophageal biopsies
View original record on NIH RePORTER →